Mosaic ImmunoEngineering (CPMV) Total Current Liabilities (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Total Current Liabilities of $6.2 million for Q1 2026, up 9.2% year-over-year from $5.7 million in Q1 2025, and up 2.44% quarter-over-quarter from $6.0 million in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Total Current Liabilities (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 9.2% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (up 9.2% YoY), while the FY2025 annual figure was $6.0 million, up 8.9% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $6.2 million, up from $6.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $6.2 million in Q1 2026, with the low at $2.7 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $4.9 million (2024), against an average of $4.8 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 122.49% in 2022, then climbed 8.9% in 2025.
- Mosaic ImmunoEngineering's Total Current Liabilities stood at $3.9 million in 2022, then climbed by 20.81% to $4.7 million in 2023, then grew by 16.99% to $5.5 million in 2024, then gained by 8.9% to $6.0 million in 2025, then rose by 2.44% to $6.2 million in 2026.
- Business Quant data shows CPMV's Total Current Liabilities at $6.2 million in Q1 2026, $6.0 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.18 Mn |
| Dec 31, 2025 | 6.03 Mn |
| Sep 30, 2025 | 5.91 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Dec 31, 2023 | 4.73 Mn |
| Sep 30, 2023 | 4.57 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.17 Mn |
| Dec 31, 2022 | 3.92 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 3.32 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 1.49 Mn |